The battle for the prescription status of methamphetamine precursor/popular cough-cold ingredient pseudoephedrine now is heating up in Kentucky, just a few days following a Nevada news report that suggested the state will be considering PSE prescription-only requirements just as soon as a bill is introduced by Nevada Sen. Sheila Leslie, D-Reno.

The forward-looking vision employed by Gov. Jay Nixon in exploring “next steps” in fighting methamphetamine abuse before even the last step has been put into place and enacted is, in a matter of speaking, extremely short-sighted. It doesn’t even make fiscal sense, because the National Precursor Log Exchange will do more to curb many of the costs associated with fighting meth addicts without conversely increasing the costs associated with fighting a cold. And truth be told, there are probably a lot more stuffy heads in Missouri than there are meth addicts.

The Food and Drug Administration has approved a generic treatment made by Impax for seasonal...

Arkansas state police apprehended and arrested a methamphetamine ring, which had been attempting to acquire...

The Consumer Healthcare Products Association is slated to testify Wednesday before an Indiana legislative committee...

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

The Consumer Healthcare Products Association on Tuesday commended the California Senate Public Safety Committee for...

Did the Combat Meth Act of 2005 not go far enough? Should the common and...

Former White House drug policy spokesman Robert Weiner and Jonathan Battaglia, a policy analyst at...

Electronic tracking or prescription-only? That’s the question that vexed Congressional leaders last month as they...

Teva Pharmaceutical Industries had net sales of $3.7 billion in first quarter 2010, a 16%...